Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.422EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.422EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.422ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.422ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.422EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.422EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.422ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.422ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.443EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.443ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.443EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.443EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.443ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.443ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.595.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.595.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.595.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.595.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.495EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.495ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.495EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.495EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.495ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.495ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.294EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.294ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.294EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.294EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.294ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.453EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.453ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.453EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.453EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.453ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.453ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used